Regular exercise plays a significant, independent role in maintaining cardiovascular health for individuals with severe obesity, even following substantial weight loss. A study published in Nature Metabolism found that while weight-loss medications like liraglutide are effective for weight maintenance, they do not replicate the vascular benefits provided by physical activity. According to the research, exercise is essential for improving blood vessel function and reducing systemic inflammation, key markers in preventing long-term heart disease and stroke.
The study, conducted by researchers at the University of Copenhagen, tracked 130 participants with severe obesity over the course of one year. All participants had initially completed a low-calorie diet, resulting in an average weight loss of 13.7 kg (30.2 lbs). Following this initial phase, the cohort was divided into four distinct groups: those who used only exercise, those who used only liraglutide, those who combined both, and a placebo group. The findings suggest that while medication supports weight management, it does not improve vascular health markers in the same manner as consistent movement.
Improving Vascular Function Through Movement
To assess cardiovascular risk, researchers measured the thickness of the carotid artery wall. A thicker artery wall is a clinical indicator of atherosclerosis, which increases the risk of blood clots and stroke. Participants who engaged in regular exercise demonstrated a 6–7% reduction in carotid artery wall thickness. Conversely, those in the medication-only and placebo groups showed no improvement in this specific vascular marker, as detailed in the Nature Metabolism findings.
Beyond structural changes in the arteries, the study observed a decrease in inflammatory markers among the physically active participants. Chronic inflammation is widely recognized as a primary driver of cardiovascular disease. By lowering these markers, exercise provides a protective effect for the heart and blood vessels that medication alone does not achieve. “The study shows that while medication supports weight maintenance, it is exercise—with or without medication—that improves vascular health,” said Signe Torekov, a professor at the biomedical sciences department at the University of Copenhagen.
The Impact of Modest Activity Levels
The cardiovascular benefits observed in the study did not require intense training. Participants in the exercise groups performed an average of two and a half hours of activity per week, primarily consisting of spinning and circuit training. These activity levels were monitored objectively using heart-rate monitors to ensure accuracy. For many participants, who were in their mid-40s and had not yet developed clinical heart disease or diabetes, this moderate commitment was sufficient to improve key cardiovascular risk factors.
The research team emphasized that these results are particularly relevant as the use of GLP-1 receptor agonists becomes more common. While the study focused on liraglutide—an earlier generation of GLP-1 medication—the findings highlight a critical distinction between weight reduction and metabolic health. “Weight-loss medication is an important tool, but our results indicate that it cannot replace exercise,” noted Torekov. The researchers suggest that integrating physical activity into standard care for severe obesity is vital for long-term health outcomes.
Future Directions in Obesity Treatment
While the study provides clear evidence regarding the benefits of exercise for vascular function, it also notes that combining medication with physical activity can lead to further weight loss and improved several markers of vascular function. The researchers observed that for those who struggle to maintain weight loss through lifestyle changes alone, medication can serve as an effective support system. However, the data confirms that pharmacological intervention should not be viewed as a standalone solution for cardiovascular protection.
As medical communities continue to evaluate the long-term impacts of newer GLP-1 medications, such as semaglutide, the University of Copenhagen team stresses that the fundamental need for physical activity remains unchanged. Replacing sedentary time with even a few hours of consistent exercise each week can significantly mitigate the cardiovascular risks associated with obesity. Further clinical research will likely continue to examine how different exercise modalities interact with various weight-loss treatments to optimize heart health.
For updates on further research regarding obesity treatment and cardiovascular health, readers can monitor announcements from the University of Copenhagen Department of Biomedical Sciences. We encourage readers to share their thoughts or experiences with integrating exercise into their own health journeys in the comments section below.